MorphoSys

MorphoSys Equity Ratio

Delisted

The Equity Ratio of MorphoSys (MOR.DE) as of Nov 18, 2026 is 2.42 %. In the previous year, Equity Ratio was 6.57 % — a change of -63.14% (lower).

Equity Ratio

2.42 %

YoY

-63.14%

Last updated:

Equity Ratio of MorphoSys is 2023 2.42 % . Equity Ratio of MorphoSys was 2022 6.57 % . It decreases by -63.14% lower compared to the previous year.

The MorphoSys Equity Ratio history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Ratio
Date
Equity Ratio
Jan 1, 2016
89.62 EUR
Jan 1, 2017
86.34 EUR
Jan 1, 2018
90.65 EUR
Jan 1, 2019
79.51 EUR
Jan 1, 2020
37.44 EUR
Jan 1, 2021
9.58 EUR
Jan 1, 2022
6.57 EUR
Jan 1, 2023
2.42 EUR
The MorphoSys Equity Ratio history
YEAREquity RatioYoY
2.42 %-63.14%
6.57 %-31.45%
9.58 %-74.41%
37.44 %-52.91%
79.51 %-12.29%
90.65 %+4.98%
86.34 %-3.65%
89.62 %+9.57%
81.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MorphoSys Stock analysis

What does MorphoSys do? MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MorphoSys stock

Equity Ratio of MorphoSys is 2.42 % in 2023.

Equity Ratio of MorphoSys changed from 6.57 % to 2.42 %, representing a -63.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Ratio MorphoSys since 2006 – with annual values, charts, and detailed analysis.

The equity ratio measures the proportion of total assets financed by shareholders' equity. Higher ratios indicate stronger financial independence and lower leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Ratio's MorphoSys with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — MorphoSys

All Key Metrics — MorphoSys